Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.300
+0.280 (6.97%)
At close: Nov 28, 2025, 1:00 PM EST
4.350
+0.050 (1.16%)
After-hours: Nov 28, 2025, 4:58 PM EST

Sana Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
49.3964.0473.367.0650.4128.27
Upgrade
Research & Development
140.81207.43253.6204.37274.66232.09
Upgrade
Operating Expenses
190.2271.47326.9271.43325.07260.36
Upgrade
Operating Income
-190.2-271.47-326.9-271.43-325.07-260.36
Upgrade
Interest & Investment Income
4.2310.479.943.760.680.75
Upgrade
Other Non Operating Income (Expenses)
5.86--0.05-0.670.310.1
Upgrade
EBT Excluding Unusual Items
-180.12-261-317.01-268.34-324.09-259.51
Upgrade
Asset Writedown
-51.01-6.4-7.01-4.5--
Upgrade
Other Unusual Items
-3.290.6440.773.36-31.84-25.79
Upgrade
Pretax Income
-234.41-266.76-283.26-269.48-355.93-285.31
Upgrade
Net Income
-234.41-266.76-283.26-269.48-355.93-285.31
Upgrade
Net Income to Common
-234.41-266.76-283.26-269.48-355.93-285.31
Upgrade
Shares Outstanding (Basic)
24323119518816613
Upgrade
Shares Outstanding (Diluted)
24323119518816613
Upgrade
Shares Change (YoY)
10.01%18.68%3.29%13.16%1178.88%165.43%
Upgrade
EPS (Basic)
-0.96-1.16-1.46-1.43-2.14-21.92
Upgrade
EPS (Diluted)
-0.96-1.16-1.46-1.43-2.14-21.92
Upgrade
Free Cash Flow
-158.85-256.58-273.61-310.93-280.92-161.85
Upgrade
Free Cash Flow Per Share
-0.65-1.11-1.41-1.65-1.69-12.44
Upgrade
EBITDA
-176.7-255.97-309.36-255.8-314-254.44
Upgrade
D&A For EBITDA
13.515.517.5415.6311.075.92
Upgrade
EBIT
-190.2-271.47-326.9-271.43-325.07-260.36
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q